Article
Identifying Reasons for ACEI/ARB Non-Use in CKD Using Scalable Clinical NLP with Schema-Guided LLM Augmentation
2026-02-12
Abstract excerpt
<h4>IMPORTANCE</h4> Although angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are recommended for people with chronic kidney disease (CKD), they remain underused. Barriers to adherence, such as adverse effects or patient refusal, are frequently embedded within unstructured clinical narratives and are therefore inaccessible to structured data analytics. Scalable natural lan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d50010b0-388b-5c54-8ee1-0834ad27becc
- DOI
- 10.64898/2026.02.10.26346025
